Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations

Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations

A gas chromatographic method has been developed for the assay of fluvastatin sodium (FLU). FLU was silylated with N,O-bis(trimethylsilyl)trifluoroacetamide-1% trimethylchlorosilane at 90 ºC for 30 min and analysed in a DB-1 column by capillary gas chromatograph with a flame ionization detector. The...

Full description

Bibliographic Details
Main Authors:	Serap Saglik Aslan, Olcay Sagirli and Lale Ersoy
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Química 2009-01-01
Series:	Química Nova
Subjects:	fluvastatin validation pharmaceutical preparations
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422009000900021

Similar Items

Rhabdomyolysis induced by co-administration of fluvastatin and colchicine
by: Filippo M. Sarullo, et al.
Published: (2015-12-01)

A COMPARISON BETWEEN FLUVASTATIN AND LOVASTATIN EFFECTS IN IRANIAN PATIENTS WITH HYPERCHOLESTEROLEMIA
by: S. Moradm, et al.
Published: (1998-08-01)

A COMPARISON BETWEEN FLUVASTATIN AND LOVASTATIN EFFECTS IN IRANIAN PATIENTS WITH HYPERCHOLESTEROLEMIA
by: S. Moradm, et al.
Published: (1998-12-01)

FLUVASTATINE EFFICIENCV IN TREATING DVSLIPIDEMIA IN THE PATIENTS AT THE PERITONEAL DIALYSIS
by: Vidojko Đorđević, et al.
Published: (2002-09-01)

Fluvastatin Influences Hair Color in C57Bl/6 Mice
by: Jarosław Jóźwiak, et al.
Published: (2013-07-01)

Fluvastatin and the Breast Cancer Risk: A Meta-analysis of Observational Studies
by: Dong-Mei Liu, et al.
Published: (2016-11-01)

Evaluate the efficacy of Simvastatin and Fluvastatin in patients with hypercholesterolemia and their effect on liver functions
by: Hassan A. H. Ali, et al.
Published: (2017-12-01)

Detrimental effects of fluvastatin on plasma lipid metabolism in rat breast carcinoma model
by: Kapinová Andrea, et al.
Published: (2013-01-01)

Fluvastatin Sodium Ameliorates Obesity through Brown Fat Activation
by: Na Yin, et al.
Published: (2019-04-01)

Dynamics of clinical, functional, and immune parameters in patients with myocardial infarction and early fluvastatin administration
by: V. V. Belov, et al.
Published: (2011-08-01)

Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri
by: Aitor Rizo-Liendo, et al.
Published: (2020-10-01)

Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin
by: Li J, et al.
Published: (2018-10-01)

DEVELOPMENT AND VALIDATION OF METHOD OF QUANTITATIVE DETERMINATION OF RESIDUAL ORGANIC SOLVENTS IN INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENT WITH GC-FID
by: E. V. Butina, et al.
Published: (2019-01-01)

FLUVASTATIN EFFECTS ON BLOOD CELL AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2013-04-01)

Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
by: Zuozhang Yang, et al.
Published: (2017-05-01)

Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia
by: T. Sh. Mirilashvili, et al.
Published: (2009-08-01)

Protective Effects of Fluvastatin on Reproductive Function in Obese Male Rats Induced by High-Fat Diet through Enhanced Signaling of mTOR
by: Xiangrong Cui, et al.
Published: (2017-02-01)

The pleotropic effects of fluvastatin on complement-mediated T-cell activation in hypercholesterolemia
by: Tawanda Maurice Nyambuya, et al.
Published: (2021-11-01)

Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan
by: Liao Kuan-Fu, et al.
Published: (2017-09-01)

Inhibition of Orbivirus Replication by Fluvastatin and Identification of the Key Elements of the Mevalonate Pathway Involved
by: Fauziah Mohd Jaafar, et al.
Published: (2021-07-01)

A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study
by: Jurij Hanžel, et al.
Published: (2015-12-01)

Colorimetric Assay of Thiamine Hydrochloride in Pharmaceutical Preparations
by: Ahmad et al.
Published: (2019-12-01)

Effect of fluvastatin on inflammatory factors, MMP-9, mAlb, Hcy and APN in patients with early diabetic nephropathy
by: Peng Ye, et al.
Published: (2016-09-01)

Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates
by: Shaimaa M. Badr-Eldin, et al.
Published: (2021-02-01)

Repurposing of Fluvastatin as an Anticancer Agent against Breast Cancer Stem Cells via Encapsulation in a Hyaluronan-Conjugated Liposome
by: Ji Su Yu, et al.
Published: (2020-11-01)

Effects of Fluvastatin on Characteristics of Stellate Ganglion Neurons in a Rabbit Model of Myocardial Ischemia
by: Li-Jun Cheng, et al.
Published: (2016-01-01)

Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells
by: Lamya H. Al-Wahaibi, et al.
Published: (2020-06-01)

Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling model
by: Jae-Ho Chang, et al.
Published: (2014-01-01)

Modulation of Ion Channels in the Superior Cervical Ganglion Neurons by Myocardial Ischemia and Fluvastatin Treatment
by: Lijun Cheng, et al.
Published: (2018-09-01)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY
by: A. V. Susekov, et al.
Published: (2016-01-01)

Quantitative analysis of ibuprofen in pharmaceuticals and human control serum using kinetic spectrophotometry
by: Mitić Snežana S., et al.
Published: (2008-01-01)

Quantitative analysis of ibuprofen in pharmaceuticals and human control serum using kinetic spectrophotometry
by: SNEZANA S. MITIC, et al.
Published: (2008-08-01)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY
by: A. V. Susekov, et al.
Published: (2016-01-01)

Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”
by: Miodrag Janić, et al.
Published: (2019-04-01)

Effect of Fluvastatin on Oxidation-reduction Function and ICAM-1 Expression in Pocine Carotid Artery Endothelial Cells Dealt with Hypoxia/Reoxygenation
by: Fukuda Daiju, et al.
Published: (2014-12-01)

Spectrophotometric Assay of Dipyrone in Pharmaceutical Preparations Via Oxidative Coupling Reaction with
by: E.S. Salih, et al.
Published: (2008-06-01)

New, simple and validated UV-spectrophotometric methods for the estimation of sodium usnate in preparations
by: Ivana Savić, et al.
Published: (2010-12-01)

Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund's adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway
by: Shahira F. El Menshawe, et al.
Published: (2019-01-01)

Fluvastatin and microRNA-146a alter interleukin-33 mediated mast cell functions.
by: Taruselli, Marcela
Published: (2019)

Spectrophotometric Determination of Chloramphenicol in Pharmaceutical Preparations
by: Tamathir A. Hamoudi, et al.
Published: (2018-06-01)